KHRN.H logo

Khiron Life Sciences Corp. Stock Price

TSXV:KHRN.H Community·CA$9.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

KHRN.H Share Price Performance

CA$0
0.00 (0.00%)
CA$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.

KHRN.H Community Narratives

There are no narratives available yet.

Snowflake Analysis

Low with weak fundamentals.

3 Risks
0 Rewards

Khiron Life Sciences Corp. Key Details

CA$16.1m

Revenue

CA$9.5m

Cost of Revenue

CA$6.7m

Gross Profit

CA$37.3m

Other Expenses

-CA$30.7m

Earnings

Last Reported Earnings
Sep 30, 2022
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About KHRN.H

Founded
2012
Employees
n/a
CEO
Alvaro Torres
WebsiteView website
khiron.ca

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Recent KHRN.H News & Updates

Recent updates

No updates